Uteroferrin and rose proteins for stimulating hematopoietic cell

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530395, 530397, 530400, A61K 3702, C07K 1506, C07K 1514

Patent

active

052583678

ABSTRACT:
Method of using uteroferrin and rose for stimulating proliferation of hematopoietic cells.

REFERENCES:
patent: 4722998 (1988-02-01), Cantor et al.
patent: 4810643 (1989-03-01), Souza
Gross et al., "Uteroferrins are Hematopoietic Growth Factors", 81st Annual Meeting of Am. Assoc. for Cancer Res., Washington, D.C., USA, May 23-26, 1990, Proc. Am. Assoc. Cancer Res. 31(0) 1990, p. 43.
Worthington-White et al., "Uteroferrin and Rose Proteins From Pig Endometrium are Hematopoietic Growth Factors", 22nd Annual Meeting of Soc. for the Study of Reprod. Columbia, Mo., USA, Aug. 6-9, 1989, Biol. Reprod. 40 (Suppl. 1), 1989, p. 112.
Baumbach et al., "Uteroferrin has N-Asparagine-Linked High-Mannose-Type Digosaccharides . . . ", PNAS USA vol. 81, May 1984, pp. 2985-2989.
Guilbert et al., "Partial Replacement of Serum by Selenite, Transferrin, Albumin . . . ", Nature, vol. 263, Oct. 14, 1976, pp. 594-595.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Uteroferrin and rose proteins for stimulating hematopoietic cell does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uteroferrin and rose proteins for stimulating hematopoietic cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uteroferrin and rose proteins for stimulating hematopoietic cell will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1757523

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.